ISSN 1470-7330

Search site with:

Content

Current Issue

Archive

Related Journals / Articles

Information

Aims and Scope

Editors and Board

Editorial Policy

Instructions for Authors

Subscription Information

Advertising

Society

Aims

Membership

Annual Meeting

Communications

Send Email to ICIS

e-Med

Visit e-Med Web Site

Journals

Purchase

“To Promote Education in Cancer Imaging in the Multidisciplinary Management of Malignancy”

Home > Articles

Whole body MRI and PET/CT in haematological malignancies Open Access Article

Abstract

The usefulness of whole body magnetic resonance imaging (MRI) and positron emission tomography (PET)/ computed tomography (CT) in haematological malignancies is reviewed. PET/CT combining functional and anatomical information is currently a valuable tool in the management of patients with lymphoma, especially in the assessment of early treatment response. MRI is advantageous in evaluating bone marrow involvement and therefore plays an important role in clinical decision making for patients with myeloma. The development of whole body functional MR studies is underway and can potentially complement the PET/CT for better patient care.

Author

Chieh Lin, Alain Luciani, Emmanuel Itti, Corinne Haioun and Alain Rahmouni

Contact Details

Corresponding address:
Alain Rahmouni, Department of Radiology, Centre Hospitalo-Universitaire Henri Mondor,
51, Avenue du Marechal de Lattre de Tassigny, 94010 Creteil, France

Reference

ICIS Cancer Imaging Volume 7 Special Issue A
DOI: 10.1102/1470-7330.2007.9004

Date Posted

1 October 2007

Open Access Article Open Access is provided for this article.

Print PDF

Size

535.73 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	2 seconds
ADSL 512Kb/s (Broadband):	8 seconds
64 Kb/s (ISDN):	1 minute 6 seconds
33.3 Kb/s (Typical Modem):	2 minutes 8 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 66356, London, E14 1GW. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.